Back

A patient on RAAS inhibitors with hyperkalemia.

25 May 2019 (11:00 - 11:15)
Organised by:
Congress Presentation Part of: Guidelines in Daily Practice I: Potassium binders Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Ewa Anita Jankowska

Wroclaw Medical University, Wroclaw (Poland)

4 More presentations in this session

Presentation thumbnail
What do the guidelines say?
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
How to implement the guidelines?
Professor M. Lainscak (Murska Sobota, SI)
Slides Video
Presentation thumbnail
Panel discussion.
Presentation thumbnail
Conclusion and take home message.
Video

Access the full session

Session thumbnail
Guidelines in Daily Practice I: Potassium binders

The Event

Event poster

Heart Failure 2019

25 May 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Risk of hyperkalemia with sacubitril/valsartan vs. RAAS inhibitor use in heart failure with reduced and preserved ejection fraction: a meta-analysis of 6 RCTs including 17,362 patients
29 June 2021
thumbnail
Congress Presentation
Primary hyperaldosteronism: a neglected cause of refractory hypertension leading to acute aortic dissection
28 August 2026
thumbnail
Congress Presentation
Proportion of patients taking indapamide developing severe hypokalaemia
27 August 2021
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources